Jilin Zixin Pharmaceutical Industrial Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 159.07 million compared to CNY 197.01 million a year ago. Revenue was CNY 159.07 million compared to CNY 197.01 million a year ago. Net loss was CNY 340.82 million compared to CNY 276.55 million a year ago. Basic loss per share from continuing operations was CNY 0.27 compared to CNY 0.22 a year ago. Diluted loss per share from continuing operations was CNY 0.27 compared to CNY 0.22 a year ago.